Concepedia
10
Publications
391
Citations
H-Index
2021
Active since
Affiliations
University of Chicago(Current)
University Medical Center Hamburg-Eppendorf
Universität Hamburg
National Center for Tumor Diseases
University Cancer Center Hamburg
Robin Reschke is an author at University of Chicago.
Publications per year
2021–2024
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
Robin Reschke, Jovian Yu, Blake Flood et al. · Journal for ImmunoTherapy of Cancer · 2021 · 172 citations · Full text
Checkpoint Blockade–Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines
Robin Reschke, Jason W. Shapiro, Jovian Yu et al. · Cancer Immunology Research · 2022 · 78 citations · Full text
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
Robin Reschke, Philipp Gussek, Andreas Boldt et al. · International Journal of Molecular Sciences · 2021 · 31 citations · Full text
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets
Robin Reschke, Alexander Enk, Jessica C. Hassel · International Journal of Molecular Sciences · 2024 · 28 citations · Full text
Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors
Julia-Christina Stadler, Laura Keller, Alexander T. Bauer et al. · Journal for ImmunoTherapy of Cancer · 2023 · 20 citations · Full text
Rows per page
1–5 of 10